Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Hepatitis

  Free Subscription


22.12.2025

1 Arch Virol
1 BMC Gastroenterol
2 Gut
2 Hepatology
1 J Clin Microbiol
1 J Hepatol
1 J Infect Dis
4 J Viral Hepat
1 J Virol
2 PLoS One
1 PLoS Pathog
1 Virology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Arch Virol

  1. SATO Y, Doi K, Inoue J, Ninomiya M, et al
    Association between deletions in the preS1/2 region of the hepatitis B virus genome and persistently abnormal ALT levels in patients with chronic hepatitis B treated with nucleos(t)ide analogs.
    Arch Virol. 2025;171:27.
    PubMed         Abstract available


    BMC Gastroenterol

  2. LI J, Yangjin B, Zhu C, Xu W, et al
    Development of a nomogram for predicting the long-term risk of hepatocellular carcinoma after antiviral treatment for hepatitis C.
    BMC Gastroenterol. 2025;25:860.
    PubMed         Abstract available


    Gut

  3. LENS S, Burton AR, Davies J, Locatelli M, et al
    Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawal.
    Gut. 2025 Dec 19:gutjnl-2024-333309. doi: 10.1136/gutjnl-2024-333309.
    PubMed         Abstract available

  4. WANG J, Zhang S, Chen Y, Fan T, et al
    Serum thrombospondin-2 as a non-invasive biomarker for liver fibrosis in chronic hepatitis B.
    Gut. 2025 Dec 17:gutjnl-2025-336665. doi: 10.1136/gutjnl-2025-336665.
    PubMed        


    Hepatology

  5. GOMEZ-ESCOBAR E, Flores N, Shoukry NH
    Erratum: One step closer to a pan-genotypic hepatitis C vaccine.
    Hepatology. 2026;83:E72.
    PubMed        

  6. HUI VW, Wong GL, Dai J, Tse YK, et al
    Increased risk of hepatocellular carcinoma in HBeAg-negative indeterminate phase compared to HBeAg-negative chronic infection.
    Hepatology. 2025 Apr 21. doi: 10.1097/HEP.0000000000001354.
    PubMed         Abstract available


    J Clin Microbiol

  7. HELM EW, Kim HN, Greninger AL
    Optimizing hepatitis C virus testing in the era of point-of-care RNA diagnostics.
    J Clin Microbiol. 2025 Dec 17:e0125925. doi: 10.1128/jcm.01259.
    PubMed         Abstract available


    J Hepatol

  8. VINCENZETTI L, Wong R, Marzi R, Guarino B, et al
    Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells.
    J Hepatol. 2026;84:62-73.
    PubMed         Abstract available


    J Infect Dis

  9. CHOWDHURY A, Garcia BG, Zahoor MA, Fadl ElMawla N, et al
    A rapid assay for HCV RNA detection using RT-LAMP coupled CRISPR-Cas12b based strategy.
    J Infect Dis. 2025 Dec 16:jiaf609. doi: 10.1093.
    PubMed         Abstract available


    J Viral Hepat


  10. Correction to "Hepatitis B Patients' Adherence to Treatment in Relation to Knowledge, Attitudes, and Practices (KAP) in the West Bank, Palestine, 2022-2023".
    J Viral Hepat. 2026;33:e70120.
    PubMed        

  11. ZHOU J, Liu K, Boor PPC, Pan Q, et al
    The Differential Effects of Immunosuppressants on Hepatitis E Virus Replication and the Triggered Inflammatory Responses in Macrophages.
    J Viral Hepat. 2026;33:e70118.
    PubMed         Abstract available

  12. RAZAVI-SHEARER D, Gamkrelidze I, Hall S, Cohen C, et al
    The Current Burden of Hepatitis B in the United States: A State, Territorial, and County Modelling Analysis.
    J Viral Hepat. 2026;33:e70122.
    PubMed         Abstract available

  13. WONG RJ, Gish RG, Jacobson IM, Lim JK, et al
    Impact of Double Reflex Testing and Linkage to Treatment on Clinical Outcomes of Chronic Hepatitis Delta Virus Infection in the United States.
    J Viral Hepat. 2026;33:e70119.
    PubMed         Abstract available


    J Virol

  14. WANG Y, Li Y, Xu R, Yuan T, et al
    GRP75 blocks hepatitis E virus infection by targeting HEV-ORF2 for degradation through chaperone-mediated autophagy and promoting IRF3 activation.
    J Virol. 2025 Dec 17:e0134425. doi: 10.1128/jvi.01344.
    PubMed         Abstract available


    PLoS One

  15. ZHANG M, Tan Y, Fang Z, Li F, et al
    Burden of liver cancer resulting from different etiologies in China from 1990 to 2021 and prediction to 2031.
    PLoS One. 2025;20:e0338908.
    PubMed         Abstract available


  16. Editorial Note: Expression of Concern: Chaperone-mediated autophagy targets IFNAR1 for lysosomal degradation in free fatty acid treated HCV cell culture.
    PLoS One. 2025;20:e0338988.
    PubMed        


    PLoS Pathog

  17. WANG Y, Murai K, Ishida A, Kawasaki N, et al
    Netrin-1 inhibits the attachment and internalization of Hepatitis B virus for hepatocyte infection.
    PLoS Pathog. 2025;21:e1013776.
    PubMed         Abstract available


    Virology

  18. ZHAO S, Wang D, Qin Y, Mao M, et al
    Decoding cross-serotype interference in duck hepatitis viruses: Trivalent IgY targeting DHAV-1, DHAV-3 and DAstV-1.
    Virology. 2025;615:110776.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.